Shares of The Westaim Co. (CVE:WED - Get Free Report) reached a new 52-week high on Tuesday . The stock traded as high as C$35.55 and last traded at C$35.55, with a volume of 786 shares. The stock had previously closed at C$33.98.
Wall Street Analysts Forecast Growth
Separately, Cormark upped their price target on Westaim from C$6.00 to C$7.75 in a research note on Wednesday, December 11th.
Check Out Our Latest Research Report on WED
Westaim Price Performance
The stock's 50-day moving average is C$23.50 and its two-hundred day moving average is C$11.06. The stock has a market cap of C$466.12 million, a P/E ratio of 71.38 and a beta of 0.39.
Westaim Company Profile
(
Get Free Report)
The Westaim Corporation is a private equity firm specializing in direct and indirect investments through acquisitions, joint ventures, secondary investments both direct and indirect, fund of fund investments, and other arrangements. For direct investments, the firm invests in early venture, mid venture, late venture, middle market, later stage, mature, emerging growth, PIPEs, and buyout transactions.
Featured Stories
Before you consider Westaim, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Westaim wasn't on the list.
While Westaim currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
